GRI Bio, Inc. SEC filings GRI

GRI Bio, Inc. has 402 filings in SEC EDGAR's recent list, going back to Sep 11, 2020. Its latest annual report, Form ARS, was filed on Sep 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.

GRI Bio, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Shareholder vote results
Nov 4, 2026 Nov 4, 2026
ARS Annual report to shareholders Sep 28, 2026 Dec 31, 2025
DEF 14A Proxy statement Sep 28, 2026 Nov 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2026 Sep 8, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
8-K Current report
Other events
Jun 18, 2026 Jun 18, 2026
8-K Current report
Results of operations, Other events
May 14, 2026 May 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
8-K Current report
Results of operations
Feb 4, 2026 Feb 4, 2026
EFFECT Filing Jan 30, 2026 —
CORRESP Letter to the SEC Jan 30, 2026 —
UPLOAD Letter from the SEC Jan 30, 2026 —
10-K Annual report Jan 30, 2026 Dec 31, 2025
8-K Current report
Material agreement
Jan 30, 2026 Jan 29, 2026
424B5 Prospectus supplement Jan 30, 2026 —
S-3 Shelf registration Jan 30, 2026 —
S-8 Employee stock plan registration Jan 30, 2026 —
8-K Current report
Other events
Jan 28, 2026 Jan 28, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jan 21, 2026 Jan 21, 2026
8-K Current report
Listing notice
Jan 16, 2026 Jan 15, 2026
8-K Current report
Shareholder vote results, Other events
Jan 15, 2026 Jan 15, 2026
8-K Current report
Other events
Jan 9, 2026 Jan 9, 2026
424B5 Prospectus supplement Jan 9, 2026 —
8-K Current report
Other events
Jan 8, 2026 Jan 8, 2026
SCHEDULE 13G Ownership over 5% (passive) Dec 29, 2025 —
DEF 14A Proxy statement Dec 29, 2025 Jan 15, 2026
PRE 14A Preliminary proxy statement Dec 19, 2025 Dec 19, 2025
SCHEDULE 13G Ownership over 5% (passive) Dec 17, 2025 —
8-K Current report
Other events
Dec 12, 2025 Dec 12, 2025
424B4 Prospectus Dec 12, 2025 —
8-K Current report
Material agreement
Dec 12, 2025 Dec 11, 2025
EFFECT Filing Dec 11, 2025 —
8-K Current report
Other events
Dec 10, 2025 Dec 10, 2025
S-1/A Amended registration statement Dec 10, 2025 —
CORRESP Letter to the SEC Dec 9, 2025 —
CORRESP Letter to the SEC Dec 9, 2025 —
S-1 Registration statement Dec 8, 2025 —
424B3 Prospectus Dec 8, 2025 —
8-K Current report
Other events
Dec 8, 2025 Dec 8, 2025
8-K Current report
Listing notice
Dec 2, 2025 Nov 26, 2025
424B3 Prospectus Nov 14, 2025 —
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Sep 22, 2025 Sep 18, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
4 Insider transaction Aug 27, 2025 Aug 26, 2025
UPLOAD Letter from the SEC Aug 22, 2025 —
8-K Current report
Regulation FD disclosure
Aug 20, 2025 Aug 20, 2025
DRSLTR Filing Aug 15, 2025 —
DRS Filing Aug 15, 2025 —
424B3 Prospectus Aug 15, 2025 —
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
4 Insider transaction Aug 14, 2025 Aug 13, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
S-8 Employee stock plan registration Aug 13, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Aug 13, 2025 Aug 13, 2025
8-K Current report
Other events
Jul 31, 2025 Jul 31, 2025
ARS Annual report to shareholders Jul 11, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 11, 2025 Aug 13, 2025
8-K Current report
Regulation FD disclosure
Jun 26, 2025 Jun 26, 2025
8-K Current report
Other events
May 23, 2025 May 23, 2025
424B5 Prospectus supplement May 23, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
8-K Current report
Other events
May 5, 2025 May 5, 2025
424B5 Prospectus supplement May 5, 2025 —
8-K Current report
Auditor change
Apr 16, 2025 Apr 11, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2025 —
424B4 Prospectus Apr 2, 2025 —
8-K Current report
Material agreement, Other events
Apr 2, 2025 Apr 1, 2025
EFFECT Filing Apr 1, 2025 —
CORRESP Letter to the SEC Mar 26, 2025 —
CORRESP Letter to the SEC Mar 26, 2025 —
S-1/A Amended registration statement Mar 26, 2025 —
S-1 Registration statement Mar 25, 2025 —
UPLOAD Letter from the SEC Mar 18, 2025 —
8-K Current report
Results of operations
Mar 17, 2025 Mar 17, 2025
DRS Filing Mar 14, 2025 —
10-K Annual report Mar 14, 2025 Dec 31, 2024
8-K Current report
Listing notice, Other events
Mar 11, 2025 Mar 10, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Feb 19, 2025 Feb 19, 2025
8-K Current report
Shareholder vote results
Feb 11, 2025 Feb 11, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
4 Insider transaction Jan 24, 2025 Jan 23, 2025
DEF 14A Proxy statement Jan 17, 2025 Feb 11, 2025
PRE 14A Preliminary proxy statement Jan 7, 2025 Feb 11, 2025
S-8 Employee stock plan registration Jan 6, 2025 —
8-K Current report
Other events
Dec 20, 2024 Dec 20, 2024
424B5 Prospectus supplement Dec 20, 2024 —
EFFECT Filing Nov 22, 2024 —
CORRESP Letter to the SEC Nov 20, 2024 —
UPLOAD Letter from the SEC Nov 20, 2024 —
424B3 Prospectus Nov 15, 2024 —
S-3 Shelf registration Nov 14, 2024 —
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
D Filing Oct 25, 2024 —
8-K Current report
Other events
Oct 24, 2024 Oct 24, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
Oct 22, 2024 Oct 21, 2024
8-K/A Amended current report
Listing notice
Sep 11, 2024 Sep 10, 2024
424B3 Prospectus Sep 11, 2024 —
424B3 Prospectus Sep 11, 2024 —
8-K Current report
Listing notice
Sep 11, 2024 Sep 10, 2024
8-K Current report
Shareholder vote results
Sep 6, 2024 Sep 6, 2024
424B3 Prospectus Aug 28, 2024 —
424B3 Prospectus Aug 28, 2024 —
424B3 Prospectus Aug 28, 2024 —
DEFA14A Additional proxy material Aug 23, 2024 —
DEFA14A Additional proxy material Aug 23, 2024 —
8-K Current report
Shareholder vote results
Aug 23, 2024 Aug 23, 2024
DEFA14A Additional proxy material Aug 16, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
ARS Annual report to shareholders Aug 2, 2024 Dec 31, 2023
DEF 14A Proxy statement Aug 2, 2024 Aug 23, 2024
8-K Current report
Other events
Jul 26, 2024 Jul 26, 2024
424B5 Prospectus supplement Jul 26, 2024 —
PRE 14A Preliminary proxy statement Jul 23, 2024 Aug 23, 2024
8-K Current report
Other events
Jul 19, 2024 Jul 19, 2024
424B5 Prospectus supplement Jul 19, 2024 —
8-K Current report
Listing notice, Other events
Jul 8, 2024 Jul 2, 2024
424B4 Prospectus Jun 27, 2024 —
8-K Current report
Material agreement, Other events
Jun 27, 2024 Jun 26, 2024
EFFECT Filing Jun 26, 2024 —
S-1/A Amended registration statement Jun 26, 2024 —
S-1/A Amended registration statement Jun 26, 2024 —
CORRESP Letter to the SEC Jun 25, 2024 —
CORRESP Letter to the SEC Jun 25, 2024 —
UPLOAD Letter from the SEC Jun 24, 2024 —
S-1 Registration statement Jun 20, 2024 —
424B3 Prospectus Jun 18, 2024 —
424B3 Prospectus Jun 18, 2024 —
8-K Current report
Officer or director change
Jun 18, 2024 Jun 17, 2024
424B3 Prospectus Jun 17, 2024 —
424B3 Prospectus Jun 17, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jun 14, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 7, 2024
424B3 Prospectus May 31, 2024 —
424B3 Prospectus May 31, 2024 —
8-K Current report
Listing notice
May 22, 2024 May 21, 2024
424B3 Prospectus May 21, 2024 —
424B3 Prospectus May 21, 2024 —
8-K Current report
Material agreement
May 20, 2024 May 20, 2024
424B5 Prospectus supplement May 20, 2024 —
EFFECT Filing May 16, 2024 —
424B3 Prospectus May 14, 2024 —
424B3 Prospectus May 14, 2024 —
CORRESP Letter to the SEC May 14, 2024 —
UPLOAD Letter from the SEC May 14, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2024 May 13, 2024
S-3 Shelf registration May 10, 2024 —
10-Q Quarterly report May 10, 2024 Mar 31, 2024
DEF 14A Proxy statement May 9, 2024 May 9, 2024
PRE 14A Preliminary proxy statement Apr 29, 2024 Apr 26, 2024
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
424B3 Prospectus Mar 28, 2024 —
424B3 Prospectus Mar 28, 2024 —
10-K Annual report Mar 28, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
424B3 Prospectus Feb 2, 2024 —
8-K Current report
Material agreement, Other events
Feb 2, 2024 Feb 1, 2024
424B4 Prospectus Feb 2, 2024 —
EFFECT Filing Feb 1, 2024 —
S-1/A Amended registration statement Jan 31, 2024 —
S-1/A Amended registration statement Jan 31, 2024 —
CORRESP Letter to the SEC Jan 30, 2024 —
CORRESP Letter to the SEC Jan 30, 2024 —
424B3 Prospectus Jan 30, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jan 30, 2024 Jan 29, 2024
424B3 Prospectus Jan 19, 2024 —
8-K Current report
Shareholder vote results
Jan 19, 2024 Jan 19, 2024
8-K Current report
Regulation FD disclosure
Jan 16, 2024 Jan 16, 2024
424B3 Prospectus Jan 8, 2024 —
DEFA14A Additional proxy material Jan 8, 2024 —
8-K Current report
Listing notice
Jan 8, 2024 Jan 5, 2024
DEF 14A Proxy statement Jan 2, 2024 Jan 2, 2024
UPLOAD Letter from the SEC Dec 26, 2023 —
S-1 Registration statement Dec 21, 2023 —
PRE 14A Preliminary proxy statement Dec 20, 2023 Dec 20, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
GRI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
, Emerging growth company
SEC CIK
1824293
Former names
Vallon Pharmaceuticals, Inc. (until Apr 21, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.